Ajax loader

Types 

Types 

Topic 

Topic 

Composition 

Composition 

Orientation 

Orientation 

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: MSD-(Merck)

RUSSIA-BUSINESS/
RTS18HU9 
June 24, 2017 
The logo of pharmaceutical company Merck Sharp & Dohme Limited (MSD) is seen on a board at the St. Petersburg... 
St. Petersburg, Russia 
The logo of MSD pharmaceutical company is seen on a board at the SPIEF 2017 in St. Petersburg 
The logo of pharmaceutical company Merck Sharp & Dohme Limited (MSD) is seen on a board at the St. Petersburg International Economic Forum 2017 (SPIEF 2017) in St. Petersburg, Russia, June 1, 2017. Picture taken June 1, 2017. REUTERS/Sergei Karpukhin 
Business
Business 
Merck Buys Schering-Plough For $41 Billion - 10 Mar 2009 
16 PICTURES 
SCHERINGPLOUGH-MERCK/
RTXCK2X 
March 09, 2009 
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would... 
Linden, UNITED STATES 
A view of the Merck & Co. campus in Linden, New Jersey 
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky (UNITED STATES BUSINESS HEALTH) 
SCHERINGPLOUGH-MERCK/
RTXCK2R 
March 09, 2009 
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would... 
Linden, UNITED STATES 
A view of the Merck & Co. campus in Linden, New Jersey 
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. ÊREUTERS/Jeff Zelevansky (UNITED STATES BUSINESS HEALTH) 
SCHERINGPLOUGH-MERCK/
RTXCK2M 
March 09, 2009 
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would... 
Linden, UNITED STATES 
A view of the Merck & Co. campus in Linden, New Jersey 
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck's pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky (UNITED STATES BUSINESS HEALTH) 
SCHERINGPLOUGH MERCK/
RTXCJUL 
March 09, 2009 
A sample of the drug Singulair made by Merck & Co. Inc. is seen in New York March 9, 2009. Merck & Co... 
New York, UNITED STATES 
A sample of the drug Singulair 
A sample of the drug Singulair made by Merck & Co. Inc. is seen in New York March 9, 2009. Merck & Co Inc announced it would acquire Schering-Plough Corp for $41 billion, uniting the makers of cholesterol drugs Zetia and Vytorin in the second megadeal for Big Pharma in weeks. REUTERS/Chip East (UNITED STATES HEALTH BUSINESS) 
THAILAND-DRUGS/
RTR1MI36 
February 17, 2007 
Efavirenz, a HIV-AIDS drug by Merck & Co., is photographed at the Phrabat Nampu Temple in Thailand's... 
Bangkok, Thailand 
Efavirenz, a HIV-AIDS drug by Merck & Co., is photographed at the Phrabat Nampu Temple in Thailand's... 
Efavirenz, a HIV-AIDS drug by Merck & Co., is photographed at the Phrabat Nampu Temple in Thailand's Lopburi Province February 17, 2007. MercK & Co. announced on Thursday price cuts for Efavirenz, in poor countries and those hard hit by the disease, including Thailand, which plans to make a copycat version of the medicine. REUTERS/Adrees Latif (THAILAND) 
Sort by 
Display 
Items per page 
Page 
of 1